|
1
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer. 17:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pontecorvi G, Bellenghi M, Puglisi R, Carè
A and Mattia G: Tumor-derived extracellular vesicles and microRNAs:
Functional roles, diagnostic, prognostic and therapeutic options.
Cytokine Growth Factor Rev. 51:75–83. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang Z, Li D, Hou S and Zhu X: The cancer
exosomes: Clinical implications, applications and challenges. Int J
Cancer. 146:2946–2959. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Q, Li Y, Liu Y, Xu W and Zhu X:
Exosomal Non-coding RNAs-Mediated crosstalk in the tumor
microenvironment. Front Cell Dev Biol. 9:6468642021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishikawa D, Yoshikawa K, Takasu C,
Kashihara H, Nishi M, Tokunaga T, Higashijima J and Shimada M:
Expression level of microRNA-449a predicts the prognosis of
patients with gastric cancer. Anticancer Res. 40:239–244. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amankwah EK, Devidas M, Teachey DT, Rabin
KR and Brown PA: Six candidate miRNAs associated with early relapse
in pediatric B-cell acute lymphoblastic leukemia. Anticancer Res.
40:3147–3153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu H, Guan Z, Cuk K, Brenner H and Zhang
Y: Circulating microRNA biomarkers for lung cancer detection in
Western populations. Cancer Med. 7:4849–4862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J,
Zhou K, Liu X, Ren X, Wang F, et al: Cancer-derived exosomal
miR-25-3p promotes pre-metastatic niche formation by inducing
vascular permeability and angiogenesis. Nat Commun. 9:53952018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
WHO Classification of Tumours Editorial
Board, . WHO Classification of Tumours: Soft Tissue and Bone
Tumours. 5th edition. IARC; Lyon: pp. 403–409. 2020
|
|
13
|
Reed DR, Hayashi M, Wagner L, Binitie O,
Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein
SC and Isakoff MS: Treatment pathway of bone sarcoma in children,
adolescents, and young adults. Cancer. 123:2206–2218. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsukamoto S, Errani C, Angelini A and
Mavrogenis AF: Current treatment considerations for osteosarcoma
metastatic at presentation. Orthopedics. 43:e345–e358. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Araki Y, Yamamoto N, Hayashi K, Takeuchi
A, Miwa S, Igarashi K, Higuchi T, Abe K, Taniguchi Y, Yonezawa H,
et al: Delayed initiation of treatment is associated with
metastasis of malignant bone tumor. Anticancer Res. 41:2993–2999.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hao H, Chen L, Huang D, Ge J, Qiu Y and
Hao L: Meta-analysis of alkaline phosphatase and prognosis for
osteosarcoma. Eur J Cancer Care (Engl). 26:e125362017. View Article : Google Scholar
|
|
17
|
Araki Y, Yamamoto N, Hayashi K, Takeuchi
A, Miwa S, Igarashi K, Higuchi T, Abe K, Taniguchi Y, Yonezawa H,
et al: Pretreatment neutrophil count and platelet-lymphocyte ratio
as predictors of metastasis in patients with osteosarcoma.
Anticancer Res. 42:1081–1089. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding WZ, Liu K, Li Z and Chen SR: A
meta-analysis of prognostic factors of osteosarcoma. Eur Rev Med
Pharmacol Sci. 24:4103–4112. 2020.PubMed/NCBI
|
|
19
|
Araki Y, Yamamoto N, Hayashi K, Takeuchi
A, Miwa S, Igarashi K, Higuchi T, Abe K, Taniguchi Y, Yonezawa H,
et al: The number of osteoclasts in a biopsy specimen can predict
the efficacy of neoadjuvant chemotherapy for primary osteosarcoma.
Sci Rep. 11:19892021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Liu S, Shi J, Li J, Wang S, Liu H,
Zhao S, Duan K, Pan X and Yi Z: The Role of miRNA in the diagnosis,
prognosis, and treatment of osteosarcoma. Cancer Biother
Radiopharm. 34:605–613. 2019.PubMed/NCBI
|
|
21
|
Raimondi L, De Luca A, Gallo A, Costa V,
Russelli G, Cuscino N, Manno M, Raccosta S, Carina V, Bellavia D,
et al: Osteosarcoma cell-derived exosomes affect tumor
microenvironment by specific packaging of microRNAs.
Carcinogenesis. 41:666–677. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang C, Sun Y, Ma S, Vadamootoo AS, Wang
L and Jin C: Identification of circulating miR-663a as a potential
biomarker for diagnosing osteosarcoma. Pathol Res Pract.
215:1524112019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujiwara T, Uotani K, Yoshida A, Morita T,
Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, et al:
Clinical significance of circulating miR-25-3p as a novel
diagnostic and prognostic biomarker in osteosarcoma. Oncotarget.
8:33375–33392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang C, Wang Q, Ma S, Sun Y, Vadamootoo
AS and Jin C: A four serum-miRNA panel serves as a potential
diagnostic biomarker of osteosarcoma. Int J Clin Oncol. 24:976–982.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Asano N, Matsuzaki J, Ichikawa M, Kawauchi
J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa
Y, et al: A serum microRNA classifier for the diagnosis of sarcomas
of various histological subtypes. Nat Commun. 10:12992019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Araki Y, Aiba H, Yoshida T, Yamamoto N,
Hayashi K, Takeuchi A, Miwa S, Igarashi K, Nguyen TD, Ishii K, et
al: Osteosarcoma-Derived small extracellular vesicles enhance tumor
metastasis and suppress osteoclastogenesis by miR-146a-5p. Front
Oncol. 11:6671092021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
National Comprehensive Cancer Network, .
NCCN Guidelines Bone Cancer. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1418April
1–2023
|
|
28
|
Amin MB, Edge SB, Greene FL, Compton CC,
Gershenwald JE, Broolland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: AJCC Cancer Staging Manual. 8th edition. Springer;
Chicago, IL: pp. 471–486. 2017, PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ihaka R and Gentleman R: R: A language for
data analysis and graphics. J Comput Graph Stat. 5:299–314. 1996.
View Article : Google Scholar
|
|
31
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
miRDB. There are 437 predicted targets for
hsa-miR-1261 in miRDB. https://mirdb.org/cgi-bin/search.cgi?searchType=miRNA&searchBox=hsa-miR-1261&full=1April
1–2023
|
|
33
|
Ji Q, Xu X, Song Q, Xu Y, Tai Y, Goodman
SB, Bi W, Xu M, Jiao S, Maloney WJ and Wang Y: miR-223-3p inhibits
human osteosarcoma metastasis and progression by directly targeting
CDH6. Mol Ther. 26:1299–1312. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pu Y, Yi Q, Zhao F, Wang H, Cai W and Cai
S: MiR-20a-5p represses multi-drug resistance in osteosarcoma by
targeting the KIF26B gene. Cancer Cell Int. 16:642016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sakthikumar S, Elvers I, Kim J, Arendt ML,
Thomas R, Turner-Maier J, Swofford R, Johnson J, Schumacher SE,
Alföldi J, et al: SETD2 is recurrently mutated in whole-exome
sequenced canine osteosarcoma. Cancer Res. 78:3421–3431. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang C, He C, Wu Z, Li F and Xiao J:
Histone methyltransferase SETD2 regulates osteosarcoma cell growth
and chemosensitivity by suppressing Wnt/β-catenin signaling.
Biochem Biophys Res Commun. 502:382–388. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yurtsever A, Yoshida T, Badami Behjat A,
Araki Y, Hanayama R and Fukuma T: Structural and mechanical
characteristics of exosomes from osteosarcoma cells explored by
3D-atomic force microscopy. Nanoscale. 13:6661–6677. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu X, Yu H and Xu Y: Ras-ERK1/2 signaling
promotes the development of osteosarcoma by regulating H2BK12ac
Through CBP. Cancer Manag Res. 11:9153–9163. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boele J, Persson H, Shin JW, Ishizu Y,
Newie IS, Søkilde R, Hawkins SM, Coarfa C, Ikeda K, Takayama K, et
al: PAPD5-mediated 3′ adenylation and subsequent degradation of
miR-21 is disrupted in proliferative disease. Proc Natl Acad Sci
USA. 111:11467–11472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faversani A, Favero C, Dioni L, Pesatori
AC, Bollati V, Montoli M, Musso V, Terrasi A, Fusco N, Nosotti M,
et al: An EBC/Plasma miRNA Signature discriminates lung
adenocarcinomas from pleural mesothelioma and healthy controls.
Front Oncol. 11:6432802021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen L, Wang K, Li L, Zheng B, Zhang Q,
Zhang F, Chen J and Wang S: Plasma exosomal miR-1260a, miR-7977 and
miR-192-5p as diagnostic biomarkers in epithelial ovarian cancer.
Future Oncol. 18:2919–2931. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mancini M, Grasso M, Muccillo L, Babbio F,
Precazzini F, Castiglioni I, Zanetti V, Rizzo F, Pistore C, De
Marino MG, et al: DNMT3A epigenetically regulates key microRNAs
involved in epithelial-to-mesenchymal transition in prostate
cancer. Carcinogenesis. 42:1449–1460. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Latchana N, DiVincenzo MJ, Regan K, Abrams
Z, Zhang X, Jacob NK, Gru AA, Fadda P, Markowitz J, Howard JH and
Carson WE III: Alterations in patient plasma microRNA expression
profiles following resection of metastatic melanoma. J Surg Oncol.
118:501–509. 2018.PubMed/NCBI
|
|
44
|
Wu D, Chang X, Tian J, Kang L, Wu Y, Liu
J, Wu X, Huang Y, Gao B, Wang H, et al: Bone mesenchymal stem cells
stimulation by magnetic nanoparticles and a static magnetic field:
Release of exosomal miR-1260a improves osteogenesis and
angiogenesis. J Nanobiotechnology. 19:2092021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li K, Rodosthenous RS, Kashanchi F,
Gingeras T, Gould SJ, Kuo LS, Kurre P, Lee H, Leonard JN, Liu H, et
al: Advances, challenges, and opportunities in extracellular RNA
biology: Insights from the NIH exRNA Strategic Workshop. JCI
Insight. 3:e989422018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Engin A: Dark-Side of Exosomes. Adv Exp
Med Biol. 1275:101–131. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Robbins PD and Morelli AE: Regulation of
immune responses by extracellular vesicles. Nat Rev Immunol.
14:195–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sinkovics JG: Molecular biology of
oncogenic inflammatory processes. I. Non-oncogenic and oncogenic
pathogens, intrinsic inflammatory reactions without pathogens, and
microRNA/DNA interactions (Review). Int J Oncol. 40:305–349.
2012.PubMed/NCBI
|
|
49
|
Ye H, Hu X, Wen Y, Tu C, Hornicek F, Duan
Z and Min L: Exosomes in the tumor microenvironment of sarcoma:
From biological functions to clinical applications. J
Nanobiotechnology. 20:4032022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cheng M, Duan PG, Gao ZZ and Dai M:
MicroRNA-487b-3p inhibits osteosarcoma chemoresistance and
metastasis by targeting ALDH1A3. Oncol Rep. 44:2691–2700. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
John AA, Prakash R and Singh D:
miR-487b-3p impairs osteoblastogenesis by targeting Notch-regulated
ankyrin-repeat protein (Nrarp). J Endocrinol. 241:249–263. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yi H, Geng L, Black A, Talmon G, Berim L
and Wang J: The miR-487b-3p/GRM3/TGFβ signaling axis is an
important regulator of colon cancer tumorigenesis. Oncogene.
36:3477–3489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang BL, Dong FL, Guo TW, Gu XH, Huang LY
and Gao DS: MiRNAs Mediate GDNF-Induced proliferation and migration
of glioma cells. Cell Physiol Biochem. 44:1923–1938. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Daniel R, Wu Q, Williams V, Clark G,
Guruli G and Zehner Z: A Panel of MicroRNAs as diagnostic
biomarkers for the identification of prostate cancer. Int J Mol
Sci. 18:12812017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Park S, Kim J, Cho Y, Ahn S, Kim G, Hwang
D, Chang Y, Ha S, Choi Y, Lee MH, et al: Promotion of tumorigenesis
by miR-1260b-targeting CASP8: Potential diagnostic and prognostic
marker for breast cancer. Cancer Sci. 113:2097–2108. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xia Y, Wei K, Hu LQ, Zhou CR, Lu ZB, Zhan
GS, Pan XL, Pan CF, Wang J, Wen W, et al: Exosome-mediated transfer
of miR-1260b promotes cell invasion through Wnt/β-catenin signaling
pathway in lung adenocarcinoma. J Cell Physiol. 235:6843–6853.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hayashi C, Fukuda T, Kawakami K, Toyoda M,
Nakao Y, Watanabe Y, Shinjo T, Sano T, Iwashita M, Yotsumoto K, et
al: miR-1260b inhibits periodontal bone loss by targeting ATF6β
mediated regulation of ER stress. Front Cell Dev Biol.
10:10612162022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zakrzewska M, Gruszka R, Stawiski K,
Fendler W, Kordacka J, Grajkowska W, Daszkiewicz P, Liberski PP and
Zakrzewski K: Expression-based decision tree model reveals distinct
microRNA expression pattern in pediatric neuronal and mixed
neuronal-glial tumors. BMC Cancer. 19:5442019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Omura T, Shimada Y, Nagata T, Okumura T,
Fukuoka J, Yamagishi F, Tajika S, Nakajima S, Kawabe A and Tsukada
K: Relapse-associated microRNA in gastric cancer patients after S-1
adjuvant chemotherapy. Oncol Rep. 31:613–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu YS, Lin H, Chen D, Yi Z, Zeng B, Jiang
Y and Ren G: A four-miRNA signature as a novel biomarker for
predicting survival in endometrial cancer. Gene. 697:86–93. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
He JH, Li BX, Han ZP, Wang L, Lv YB, Zhou
JB, Cao MR, Li YG and Zhang JZ: Snail-activated long non-coding RNA
PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby
promotes invasion and migration of prostate cancer cells. Tumour
Biol. Oct 14–2016.(Epub ahead of print). View Article : Google Scholar
|
|
62
|
Lyu N, Zeng Y, Kong Y, Chen Q, Deng H, Ou
S, Bai Y, Tang H, Wang X and Zhao M: Ferroptosis is involved in the
progression of hepatocellular carcinoma through the
circ0097009/miR-1261/SLC7A11 axis. Ann Transl Med. 9:6752021.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Cao F, Liu S, Li Z, Meng L, Sang M and
Shan B: Activation of circ_0072088/miR-1261/PIK3CA pathway
accelerates lung adenocarcinoma progression. Thorac Cancer.
13:1548–1557. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhu Y, Cao F, Liu F, Liu S, Meng L, Gu L,
Zhao H, Sang M and Shan B: Identification of potential circular RNA
biomarkers in lung adenocarcinoma: A bioinformatics analysis and
retrospective clinical study. Oncol Lett. 23:1442022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chen R, Zhao WQ, Fang C, Yang X and Ji M:
Histone methyltransferase SETD2: A potential tumor suppressor in
solid cancers. J Cancer. 11:3349–3356. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Das S, Idate R, Regan DP, Fowles JS, Lana
SE, Thamm DH, Gustafson DL and Duval DL: Immune pathways and TP53
missense mutations are associated with longer survival in canine
osteosarcoma. Commun Biol. 4:11782021. View Article : Google Scholar : PubMed/NCBI
|
